Pioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome

Glucocorticoids are the primary therapy for nephrotic syndrome (NS), but have serious side effects and are ineffective in ~20–50% of patients. Thiazolidinediones have recently been suggested to be renoprotective, and to modulate podocyte glucocorticoid-mediated nuclear receptor signaling. We hypothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, S., Chanley, M. A., Westbrook, D., Nie, X., Kitao, T., Guess, A. J., Benndorf, R., Hidalgo, G., Smoyer, W. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855145/
https://www.ncbi.nlm.nih.gov/pubmed/27142691
http://dx.doi.org/10.1038/srep24392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855145/
https://www.ncbi.nlm.nih.gov/pubmed/27142691
http://dx.doi.org/10.1038/srep24392

Ejemplares similares